We are excited to share that Loargys (pegzilarginase) has been approved in Saudi Arabia. This is another important milestone for families living with Arginase 1 Deficiency (ARG1-D) around the world.
With this approval, more families may soon have access to a treatment that offers hope for better health, improved quality of life, and brighter futures.
Each new country that approves treatment brings us one step closer to our goal: ensuring that every person living with ARG1-D, no matter where they live, has access to treatment and hope.
Few but Mighty Warriors, together we are making a difference.
